LMA Clinical Trials in Paris
7 recruitingParis, France
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
Angelman Syndrome
Ultragenyx Pharmaceutical Inc60 enrolled22 locationsNCT07157254
Recruiting
Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome
Angelman Syndrome
Assistance Publique - Hôpitaux de Paris60 enrolled1 locationNCT06737718
Recruiting
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Beckwith-Wiedemann SyndromePrader-Willi SyndromePseudohypoparathyroidism+6 more
Institut National de la Santé Et de la Recherche Médicale, France2,000 enrolled20 locationsNCT05945576
Recruiting
Phase 1Phase 2
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
Methylmalonic Acidemia
ModernaTX, Inc.56 enrolled12 locationsNCT05295433
Recruiting
Phase 1Phase 2
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
Angelman Syndrome
Ionis Pharmaceuticals, Inc.70 enrolled11 locationsNCT05127226
Recruiting
Phase 3
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
Palmar or Plantar Warts
Assistance Publique - Hôpitaux de Paris146 enrolled1 locationNCT04814446
Recruiting
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Propionic AcidemiaMethylmalonic Acidemia
RECORDATI GROUP95 enrolled32 locationsNCT04176523